Persistent elevation of peripheral blood myeloid cell counts associated with omalizumab therapy

A case of persistent hematologic abnormalities in a patient receiving long-term omalizumab therapy for severe asthma is reported. During the course of her treatment at an asthma clinic, a 24-year-old woman was noted to have increased white blood cell counts, with elevated myeloid cell counts; the bl...

Ausführliche Beschreibung